3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Myelodysplastic Syndromes
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Graft vs Host Disease
2
Myeloproliferative Disorders
1
Lymphoma, Mantle-Cell
1
Lymphoma
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Biphenotypic, Acute
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Cyclophosphamide
75
fludarabine phosphate
73
Peripheral Blood Stem Cell Transplantation
59
Mycophenolic Acid
53
Tacrolimus
51
Whole-Body Irradiation
48
Busulfan
42
Antilymphocyte Serum
40
Cyclosporine
38
Filgrastim
32
fludarabine
31
Methotrexate
30
Melphalan
29
Radiotherapy
22
Methylprednisolone
18
Cord Blood Stem Cell Transplantation
17
Etoposide
16
Sirolimus
14
Alemtuzumab
13
Flow Cytometry
12
Cyclosporins
12
thymoglobulin
11
Granulocyte Colony-Stimulating Factor
11
Cytarabine
10
Psychiatric Rehabilitation
9
sargramostim
8
Thiotepa
8
Rituximab
8
Therapeutics
7
Stem Cell Transplantation
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Myeloproliferative Disorders
×
Calcineurin Inhibitors
×
Lymphoid
×
Clear all
NCT01749111
2017-03-03
CICLODECH
Hospital Israelita Albert Einstein
Phase 3
Terminated
3 enrolled